ROYCE & ASSOCIATES LP - SYNERON MEDICAL LTD ownership

SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 81 filers reported holding SYNERON MEDICAL LTD in Q2 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of SYNERON MEDICAL LTD
ValueSharesWeighting
Q2 2017$758,000
+3.8%
69,2000.0%0.01%0.0%
Q1 2017$730,000
+25.6%
69,2000.0%0.01%
+25.0%
Q4 2016$581,000
-80.7%
69,200
-83.5%
0.00%
-80.0%
Q3 2016$3,012,000
-50.3%
420,659
-46.6%
0.02%
-50.0%
Q2 2016$6,061,000
+16.3%
788,159
+10.5%
0.04%
+21.2%
Q1 2016$5,213,000
+2.0%
713,159
+7.5%
0.03%
+6.5%
Q4 2015$5,113,000
+15.6%
663,159
+7.2%
0.03%
+34.8%
Q3 2015$4,422,000
-4.8%
618,459
+41.3%
0.02%
+15.0%
Q2 2015$4,647,000
-33.3%
437,559
-22.2%
0.02%
-23.1%
Q1 2015$6,962,000
-15.4%
562,359
-36.2%
0.03%
-10.3%
Q4 2014$8,227,000
-16.8%
881,759
-10.7%
0.03%
-12.1%
Q3 2014$9,890,000
-2.9%
987,0590.0%0.03%
+10.0%
Q2 2014$10,186,000
-21.9%
987,059
-5.7%
0.03%
-23.1%
Q1 2014$13,037,000
-11.0%
1,047,159
-12.1%
0.04%
-7.1%
Q4 2013$14,650,000
+42.7%
1,191,0590.0%0.04%
+35.5%
Q3 2013$10,267,000
-0.9%
1,191,0590.0%0.03%
-3.1%
Q2 2013$10,362,0001,191,0590.03%
Other shareholders
SYNERON MEDICAL LTD shareholders Q2 2017
NameSharesValueWeighting ↓
NORTH TIDE CAPITAL, LLC 3,000,000$31,650,0004.86%
Discovery Group I, LLC 1,221,310$12,885,0004.30%
Kenmare Capital Partners, L.L.C. 389,177$4,106,0003.98%
Profit Investment Management, LLC 237,217$2,503,0002.03%
Senvest Management, LLC 2,202,272$23,234,0001.66%
PERRITT CAPITAL MANAGEMENT INC 426,370$4,498,0001.14%
Camber Capital Management LP 2,347,593$24,767,0001.00%
DALTON GREINER HARTMAN MAHER & CO 1,645,048$17,355,0000.99%
Lapides Asset Management, LLC 396,800$4,186,0000.78%
DAFNA Capital Management LLC 85,947$907,0000.77%
View complete list of SYNERON MEDICAL LTD shareholders